Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice

Transcription factor EB (TFEB)-based gene therapy is a promising therapeutic strategy in treating neurodegenerative diseases by promoting autophagy/lysosome-mediated degradation and clearance of misfolded proteins that contribute to the pathogenesis of these diseases. However, recent findings have s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenyu, Ding, Guangqian, Wang, Yudi, Zheng, Zelong, Lv, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711953/
https://www.ncbi.nlm.nih.gov/pubmed/33335764
http://dx.doi.org/10.1515/tnsci-2020-0132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711953/
https://www.ncbi.nlm.nih.gov/pubmed/33335764
http://dx.doi.org/10.1515/tnsci-2020-0132

Ejemplares similares